South Cone Investments Limited Partnership, 10% Owner at Rani Therapeutics Holdings, Inc. (RANI), bought 49,100 shares at $8.21 ($399K) on 2022-12-13, disclosed to the SEC on 2022-12-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.04 | 12,500 | $100K | 25.2% |
| 2 | $8.04 | 12,500 | $101K | 25.2% |
| 3 | $8.21 | 12,050 | $99K | 24.8% |
| 4 | $8.21 | 12,050 | $99K | 24.8% |
| Total | $8.12 avg | 49,100 | $399K | 100% |
| Filing → |
| RANI | BUY | 2023-12-08 | $21.2M | — | Filing → |
| RANI | BUY | 2023-05-05 | $10K | — | Filing → |
| RANI | BUY | 2023-05-02 | $10K | — | Filing → |